Trial intelligence / Profile preview

Reconsolidation intervention with propranolol for traumatized healthcare workers

2020-003563-26Phase 4Active

Sponsor
TNO
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by TNO. Started Aug 2020; status: active.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on 2020-003563-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-003563-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call